Emerging roles for antiangiogenesis factors in management of ocular disease

The first antivascular endothelial growth factor (anti-VEGF) was developed as an anticancer drug for colonic carcinomas. Since then, anti-VEGFs have developed in scope and indications. They have revolutionized the treatment of exudative macular degeneration and have had a major impact on treatment o...

Descripción completa

Detalles Bibliográficos
Autores principales: Saeed, Muhammad Usman, Gkaragkani, Evangelia, Ali, Kashif
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3601643/
https://www.ncbi.nlm.nih.gov/pubmed/23515639
http://dx.doi.org/10.2147/OPTH.S31016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3601643/
https://www.ncbi.nlm.nih.gov/pubmed/23515639
http://dx.doi.org/10.2147/OPTH.S31016

Ejemplares similares